How Does Cardinal Health Company Work?

How does Cardinal Health power U.S. healthcare distribution?

With fiscal 2025 revenue above $245 billion, Cardinal Health moves nearly 25% of U.S. pharmaceuticals and serves over 90% of hospitals, making it a backbone of medical supply chains.

As a Big Three wholesaler, Cardinal Health combines large-scale logistics, data analytics, and specialty product growth to operate high-volume, low-margin distribution networks while expanding into digital health and specialty services.

Explore strategic context: Cardinal Health Porter's Five Forces Analysis

Cardinal Health operates through two primary segments — Pharmaceutical and Medical — providing distribution, manufacturing, and integrated supply solutions that enable healthcare providers to run leaner inventories and deliver care efficiently.

Pharmaceutical Segment

The Pharmaceutical segment sources and distributes branded and generic drugs, OTC products, and specialty items, leveraging national scale to support retail chains, independent pharmacies, and mail-order providers.

Logistics & Inventory

A sophisticated logistics network enables next-day delivery and just-in-time stocking, reducing waste and working capital for customers across hospitals and pharmacies.

Medical Segment

The Medical segment manufactures and distributes medical, surgical, and laboratory products, from gloves and gowns to fluid management systems, under a streamlined Global Products and Supply Chain model.

One-Stop Provider

Integrated procurement, data-driven inventory management tools, and consolidated sourcing provide hospitals and clinics a single-vendor solution that reduces administrative burden and inventory waste.

Cardinal Healths business model emphasizes scale, purchasing power, and distribution efficiency; in fiscal 2025 the company reported consolidated revenues near $180 billion, with the Pharmaceutical segment accounting for the majority of volumes and the Medical segment improving margins via supply-chain consolidation.

Core Operational Advantages

Key strengths driving the Cardinal Health company structure include broad supplier relationships, advanced logistics, and digital inventory solutions that support clinical workflows.

• Extensive distribution footprint enabling next-day delivery across the US
• Purchasing scale that negotiates favorable terms and passes cost savings to customers
• Manufacturing consolidation under Global Products and Supply Chain to boost resilience
• Data-driven inventory management that reduces waste and lowers operating costs

For further context on competitive positioning and market dynamics, see Competitors Landscape of Cardinal Health.

Complete Cardinal Health Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

Cardinal Health's revenue mix in fiscal 2025 is led by the Pharmaceutical segment, which generated approximately 92% of total net sales through high-volume distribution fees and buy-side margins; the Medical segment provided the remaining 8%, with a strategic push toward higher-margin proprietary products and services.

Pharmaceutical distribution dominance

The Pharmaceutical segment drives core cash flow via large-scale drug distribution and margin capture between manufacturer purchase prices and customer pricing.

Specialty pharmaceuticals growth

Specialty drugs for oncology and complex conditions deliver higher margins and are sold under fee-for-service arrangements with manufacturers for data and clinical support.

Buy-side margin mechanics

Profitability rests on tight purchasing terms with manufacturers and scale-driven distribution fees across pharmacies, health systems, and clinics.

Medical segment monetization

Medical revenues come from Cardinal-branded and third-party medical products plus recurring service contracts for inventory and supply-chain solutions.

Value-added services

WaveMark and other supply-chain platforms using RFID and analytics produce recurring revenue and increase customer retention in hospitals and health systems.

Strategic product mix shift

In 2025 the company increased the share of proprietary, higher-margin medical products to improve operating income and gross margin profiles.

Key monetization levers include distribution scale, specialty pharmacy services, proprietary product sales, and recurring service contracts that enhance the Cardinal Health business model and how Cardinal Health operates; see a focused company overview in Marketing Strategy of Cardinal Health.

Revenue and margin drivers — snapshot

Fiscal 2025 financials and operational levers that explain Cardinal Health revenue streams and operations.

• Pharmaceutical segment: approximately 92% of revenue, driven by distribution volume and buy-side margin.
• Specialty pharmaceuticals: higher-margin growth area using fee-for-service manufacturer contracts and clinical-data services.
• Medical segment: roughly 8% of revenue, targeted for margin expansion via proprietary products.
• Service revenues: WaveMark RFID and supply-chain management deliver recurring contracts and higher customer stickiness.

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

Cardinal Health’s key milestones and strategic moves since 2024 pivot the company from distribution toward integrated clinical services, driven by specialty acquisitions and fortified by scale, compliance, and cold‑chain infrastructure.

Specialty expansion

The 2024–2025 acquisition of Integrated Oncology Network for $1.1 billion expanded Cardinal Health’s community oncology footprint and added clinical trial and data analytics capabilities.

Integration of Specialty Networks

Earlier integration of Specialty Networks strengthened services in urology and gastroenterology, converting product distribution into embedded provider workflows and care‑path support.

Scale and infrastructure

Cardinal Health’s distribution scale and cold‑chain logistics form a durable moat, enabling nationwide pharmaceutical and medical product delivery with complex regulatory compliance.

Financial resilience

Despite opioid‑related settlements, Cardinal Health maintained investment‑grade ratings, scheduled payments through 2038, and returned capital via dividends and $1.5+ billion of buybacks in fiscal 2025.

The company’s evolving Cardinal Health business model emphasizes clinical integration across its segments while preserving its core distribution network and regulatory capabilities.

Competitive edge and strategic focus

Key strategic pillars driving How Cardinal Health operates and its company structure include specialty care, scale economics, and compliance-backed logistics.

• Transition from box mover to clinical partner through specialty acquisitions and provider workflow integration
• Extensive supply chain and cold‑chain assets supporting pharmaceutical distribution process and hospital solutions
• Robust compliance framework mitigating legal and regulatory risk while preserving credit ratings
• Capital allocation policy balancing shareholder returns with investments in Specialty and data analytics

For historical context on the company’s evolution and earlier milestones, see Brief History of Cardinal Health

Cardinal Health Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

Cardinal Health sits alongside Cencora and McKesson in the U.S. pharmaceutical distribution oligopoly, combining wholesale distribution with a large medical-surgical portfolio; key risks include drug pricing legislation and new entrants like Amazon Pharmacy, while future growth targets hinge on Medical Excellence, Specialty and Nuclear scaling and AI-driven supply chain optimization.

Industry placement

Cardinal Health operates as one of three dominant national distributors, with a business model blending pharmaceutical distribution and medical-surgical sales that supports hospitals, clinics and pharmacies.

Competitive profile

While slightly smaller in pure drug distribution versus McKesson and Cencora, Cardinal Health leverages a large medical-surgical segment and growing specialty services to differentiate its company structure and services.

Key risks

Legislative pressure such as the Inflation Reduction Act’s Medicare negotiation provisions may compress distribution margins and alter Cardinal Health revenue streams and operations.

Market disruption

Non-traditional entrants and e-commerce players force investment in digital platforms and last-mile logistics to protect the distribution network and patient care solutions business.

Management outlines a path to mid-single-digit revenue growth and double-digit EPS growth through operational improvements, targeted M&A and scaling of higher-margin Specialty and Nuclear segments; by 2026 the company aims to deploy AI across the Cardinal Health supply chain to forecast demand and reduce shortages.

Strategic priorities and metrics

Key initiatives focus on Medical Excellence turnaround, specialty growth and digital transformation to secure long-term relevance in healthcare distribution.

• Scale Specialty and Nuclear to capture higher-margin revenue — management cites targeted segment growth above company average
• Implement AI-driven supply chain tools by 2026 to improve forecasting and inventory turns
• Protect distribution margins against pricing reforms through cost savings and service differentiation
• Pursue focused M&A to expand Cardinal Health services and distribution capabilities

For a deeper operational and strategic review see Growth Strategy of Cardinal Health.

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE